Doug Nissinoff

Co-Founder

Tampa, Florida, United States9 yrs 2 mos experience
Most Likely To SwitchAI Enabled

Key Highlights

  • Founded a VC fund focused on AI in healthcare.
  • Consulted for over 25 startups in biotech.
  • Expert in evaluating AI-driven healthcare investments.
Stackforce AI infers this person is a Healthcare Venture Capitalist with expertise in AI-driven biotech investments.

Contact

Skills

Core Skills

Venture CapitalAi HealthcareProject Management

Other Skills

AIHealthcareInvestment StrategyResearchMarket ExpansionSalesPublic SpeakingMicrosoft OfficeMicrosoft ExcelMicrosoft WordMarketingEmergency MedicineLaboratoryLife SciencesData Analysis

About

I’m building Intelligence Ventures — a VC fund backing the founders using AI to reshape healthcare from the ground up. We invest at pre-seed and seed into four verticals: biotech & pharma tools, medical devices, diagnostics, and healthcare SaaS. Every company in our portfolio has AI at its core and a clear path to transforming how patients are diagnosed, treated, or managed. What makes us different: our Executive LP Committee. We’ve assembled a group of physicians and healthcare executives who don’t just write checks — they evaluate deals monthly alongside our team. Founders get capital backed by the clinical and operational expertise that actually moves the needle in healthcare. We’ve screened 500+ AI healthcare startups and deployed into companies solving real problems — from AI-driven cardiac monitoring to next-generation liver disease diagnostics. If you’re building in this space across the US or Canada, I want to hear from you. Before venture, I spent years in the trenches of biotech — from clinical research to investor relations at a publicly traded gene therapy company. I hold an MS in Biotechnology from Georgetown University. That operating background isn’t decorative. It’s how I evaluate science, separate signal from noise, and earn founders’ trust on day one. Outside the fund, I’ve consulted for 25+ startups on everything from financing strategy and competitive intelligence to stepping in as a fractional CXO — Chief Whatever You Need Me To Be Officer. If there’s a gap in your leadership team, I’ve probably filled it. I share the fund-building journey transparently here on LinkedIn — the wins, the lessons, the real numbers. That’s attracted 20,000+ of you to follow along, and it’s become my strongest channel for deal flow, LP conversations, and partnerships. 🧬 Apply for funding → intelligencevc.com 💼 Invest in our fund → intelligencevc.com/#Investwithus 📫 Consulting/Everything else → info@intelligencevc.com I follow up with everyone through these channels. Talk soon!

Experience

9 yrs 2 mos
Total Experience
1 yr 6 mos
Average Tenure
3 yrs 4 mos
Current Experience

University of south florida

Venture Development

Nov 2024Mar 2026 · 1 yr 4 mos · Tampa, FL

Intelligence ventures

General Partner, Founder

Feb 2023Present · 3 yrs 4 mos · United States

  • Intelligence Ventures is a pre-seed and seed-stage fund built on a simple premise: the best investments in AI healthcare come from studying the space deeper than anyone else.
  • Before we wrote our first check, we spent years mapping the earliest-stage AI healthcare pipeline in North America, company by company, deck by deck. We published what we learned. We still do. That research is what drives every investment decision we make.
  • We invest across four verticals where AI is reshaping healthcare: biotech and pharma tools, medical devices, diagnostics, and healthcare SaaS. US and Canada. Our filter is simple: if your core advantage is a proprietary dataset that makes your models smarter over time, we want to talk.
  • If AI is a feature and not the product, we're probably not the right fit.
  • Our pipeline grows by 20-30 new companies every week through inbound alone. Our acceptance rate is below 1%. Not as a vanity metric, but because we've studied this landscape long enough to know what works.
  • Founders: apply at intelligencevc.com. LPs: read our research first. We'd rather you judge our thesis than take our word for it.
Venture CapitalAIHealthcareInvestment StrategyResearchAI Healthcare

Graphite bio

Investor Relations

Jun 2022Feb 2023 · 8 mos · San Francisco Bay Area · Remote

  • A next-generation gene editing company driven to discover and develop cures for patients living with serious diseases.

Jakob and partners

2 roles

Project Manager

Promoted

Feb 2021May 2022 · 1 yr 3 mos · Fort Lauderdale, Florida, United States

  • Spearheaded the expansion of a Danish biotech/pharma consulting firm to the United States.

Research Analyst

Mar 2020Feb 2021 · 11 mos · Fort Lauderdale, Florida, United States

Stern investor relations

Biotech Investor Relations Analyst

Dec 2018Dec 2019 · 1 yr · New York, New York

  • Curis (CRIS), Forty Seven (Acquired by Gilead for $4.9B), Fulcrum Therapeutics (FULC), Immunocore (IMCR), Innovative Cellular Therapeutics (Private Co), Ironwood Pharmaceuticals (IRWD), Neos Therapeutics (Merged with Aytu BioScience), Sage Therapeutics (SAGE), Schrödinger (SDGR), and Xencor (XNCR).

Astrazeneca

Performance & Metrics Associate (Graduate Internship)

Jan 2018Apr 2018 · 3 mos · Gaithersburg, Maryland

Olympian clinical research

Clinical Research Coordinator

Jan 2016Jan 2017 · 1 yr · Tampa/St. Petersburg, Florida Area

Florida state university

Laboratory Assistant

Jan 2014Jan 2015 · 1 yr · Tallahassee, Florida

Education

Georgetown University

Master of Science — Biotechnology

Florida State University

Bachelor of Science — Biological Science

Stackforce found 100+ more professionals with Venture Capital & Ai Healthcare

Explore similar profiles based on matching skills and experience